Cetirizine Amidine Sodium

头孢嗪脒钠

Report date: 2024/04/16 20:00:32
NME

Base Information

Drug NameCetirizine Amidine Sodium
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsCommunity Acquired PneumoniaPneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesGuangzhou Baiyunshan Pharmaceutical Holdings Company Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGuangzhou Baiyunshan Pharmaceutical Co Ltd Guangzhou Baiyunshan Pharmaceutical GeneralSouth China Center For Innovative Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsCommunity Acquired Pneumonia
Inactive IndicationsPneumonia

Other Information

ATC CodeN/A
Related LinksN/A